"Small Molecule Boosts Cartilage Repair in Old Mice"

A Small Molecule Regenerates Cartilage in Aged Mice

There are ramifications for long-term healing in younger people.

Date: January 9, 2026

• 15-PGDH, which increases with age, harms tissue regeneration in animals.
• Inhibiting this molecule led to better outcomes in a murine model.
• Similar results were found in human cartilage in vitro.

By inhibiting the aging-related enzyme 15-PGDH, scientists have shifted cartilage cells towards a healthier phenotype [1].

The Hard-to-Repair Part

Articular cartilage (the smooth, load-bearing cartilage on the ends of bones) doesn’t repair well with age or after injury [2], which is why osteoarthritis is difficult to treat. This disease affects 1 in 5 adults, leading to reduced quality of life for 33 million patients in the US alone. Current treatments primarily focus on pain relief and joint replacement, with no approved therapies targeting the cartilage loss that causes osteoarthritis.

Previous research has shown that 15-hydroxyprostaglandin dehydrogenase (15-PGDH) increases with age in multiple tissues and can blunt regeneration by degrading key prostaglandins, lipid signaling molecules that influence inflammation and tissue repair. In earlier models, which studied muscle, nerve, bone, and blood, inhibition of 15-PGDH boosted endogenous prostaglandin signaling and improved tissue repair [3].

Since osteoarthritis is fundamentally a problem of failed repair in articular cartilage, and cartilage regeneration strategies based on endogenous repair have been limited, a team led by researchers from Stanford Medicine decided to investigate the role of 15-PGDH in aged and injured cartilage. Their study was published in the journal Science.

More Healthy Cartilage

Using immunohistochemistry on knee joints from young (4 months) and aged (24 months) mice, the team discovered that cells expressing 15-PGDH were present in multiple joint tissues. In cartilage specifically, 15-PGDH abundance was about twice as high in aged mice. Aged knee joints had significantly thinner cartilage and multiple breaks in the cartilage surface.

A cohort of aged male mice was treated daily intraperitoneally with a small molecule 15-PGDH inhibitor (PGDHi) for one month. The results indicated that the knee joints of PGDHi-treated aged mice showed increased cartilage thickness and uniformity, almost on par with young mice.

The “extra” cartilage in treated aged mice was not fibrous and rough, as often occurs after an injury heals, but bore many signs of normal cartilage, with increased expression of type II collagen (COL-2), aggrecan (ACAN), the main structural building blocks of healthy cartilage, and lubricin (PRG4), a surface lubricant that helps cartilage glide with low friction.

Safranin O staining: red/orange marks proteoglycan-rich cartilage matrix (healthier cartilage); fading indicates cartilage matrix depletion.

Joint Delivery and Injury Response

The researchers wanted to determine whether local joint delivery would suffice in an injury-driven osteoarthritis model. Three-month-old male mice were treated with a series of intra-articular injections of PGDHi starting one week after injury, twice a week for two weeks. The response mirrored what the team had observed with systemic administration: improved cartilage quality, higher COL-2 levels, and increased aggrecan/lubricin. Pain responses were also better in treated mice: PGDHi-injected mice looked closer to uninjured controls across gait and mechanical pain measures. This experiment is particularly relevant to young people: even after a successful repair, half of those who suffer an ACL tear develop osteoarthritis in the injured joint within approximately 15 years.

No Stem Cells Involved

Tissue regeneration often involves the proliferation and differentiation of stem cells. However, such cells in cartilage have rarely been observed, which might explain why cartilage regeneration is subpar. The team made an exciting discovery: the regeneration they witnessed was predominantly due to gene expression changes in existing differentiated cartilage cells rather than stemming from stem cell expansion.

The researchers identified multiple chondrocyte clusters in aged cartilage and described three types that shift with PGDHi. Hypertrophic chondrocytes, which drive cartilage ossification, showed high expression of 15-PGDH. The treatment lowered the abundance of this subtype from 8% to 3%. Another largely harmful subset, fibro-chondrocytes, declined from 16% to 8% with PGDHi treatment.

Conversely, the healthy subtype that actively maintains the extracellular matrix increased in prevalence from 22% to 42%. There was no evidence of drastically increased cellular division, supporting the idea that the positive effects primarily stemmed from the existing cells shifting their behavior.

Human Relevance

To enhance human relevance, the researchers studied samples from 11 osteoarthritis patients undergoing knee replacement. They found signs of increased 15-PGDH expression and lower prostaglandin levels. Ultimately, when human cartilage was treated with PGDHi in vitro, results mirrored those seen in mice, with increased stiffness indicating healthy load-bearing behavior.

“This is a new way of regenerating adult tissue, and it holds significant clinical promise for treating arthritis due to aging or injury,” said Helen Blau, PhD, professor of microbiology and immunology and a senior author of the study. “We were looking for stem cells, but they are clearly not involved. We are very excited about this potential breakthrough. Imagine regrowing existing cartilage and avoiding joint replacement.”

“Millions of people suffer from joint pain and swelling as they age,” added Nidhi Bhutani, PhD, associate professor of orthopedic surgery and another senior author. “It is a huge unmet medical need. Until now, there has been no drug that directly treats the cause of cartilage loss. But this [PGDH] inhibitor induces a dramatic regeneration of cartilage beyond that reported in response to any other drug or intervention. Cartilage regeneration to such an extent in aged mice surprised us. The effect was remarkable.”

Literature

• [1] Singla, M., Wang, Y. X., Monti, E., Bedi, Y., Agarwal, P., Su, S., … & Bhutani, N. (2025). Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration. Science, eadx6649.
• [2] Hu H, et al. “Endogenous Repair and Regeneration of Injured Articular Cartilage: A Challenging Balance.” Cells. 2021.
• [3] Palla, A. R., Ravichandran, M., Wang, Y. X., Alexandrova, L., Yang, A. V., Kraft, P., … & Blau, H. M. (2021). Inhibition of prostaglandin-degrading enzyme 15-PGDH rejuvenates aged muscle mass and strength. Science, 371(6528), eabc8059.

About the Author

Arkadi Mazin

Arkadi is a seasoned journalist and op-ed author with a passion for learning and exploration. His interests span from politics to science and philosophy. Having studied economics and international relations, he is particularly interested in the social aspects of longevity and life extension. He strongly believes that life extension is an achievable and noble goal that has yet to take its rightful place at the top of our civilization’s agenda – a situation he is eager to change.

We would like to ask you for a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future.

Campaign Status

Receive our Newsletter

Sign up to stay informed about the latest news and opportunities with LRI!